{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:34:42Z","timestamp":1784709282064,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118336","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:18:17Z","timestamp":1762463897000},"page":"118336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Synthesis of \u03b2-boswellic acid-amino acid conjugates for targeting KRASG13D mutant colon cancer"],"prefix":"10.1016","volume":"302","author":[{"given":"Arem","family":"Qayum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mohmad","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Sakib","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashir Javed","family":"Mintoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiem Ahmed","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkishor","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-0002","authenticated-orcid":false,"given":"Bhahwal Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmech.2025.118336_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/bip.22307","article-title":"Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation","volume":"100","author":"Kwak","year":"2013","journal-title":"Biopolymers"},{"issue":"16","key":"10.1016\/j.ejmech.2025.118336_bib2","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/j.bmcl.2012.06.080","article-title":"Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants","volume":"22","author":"Dang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118336_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/jm950670t","article-title":"Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action","volume":"39","author":"Evers","year":"1996","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118336_bib4","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.bmcl.2005.07.087","article-title":"Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity","volume":"15","author":"Liang","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118336_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/81359","article-title":"Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation","volume":"6","author":"Rothbard","year":"2000","journal-title":"Nat. Med."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118336_bib6","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.bmcl.2009.06.046","article-title":"Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells","volume":"19","author":"Drag-Zalesinska","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"9","key":"10.1016\/j.ejmech.2025.118336_bib7","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3390\/molecules23092318","article-title":"Amino acids in the development of prodrugs","volume":"23","author":"Vale","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118336_bib8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.bmc.2008.12.043","article-title":"In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates","volume":"17","author":"Kim","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118336_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.53388\/TMR20240128002","article-title":"Boswellic acids: a review on its pharmacological properties, molecular mechanism and bioavailability","volume":"9","author":"Cui","year":"2024","journal-title":"Traditional Medicine Research"},{"key":"10.1016\/j.ejmech.2025.118336_bib10","article-title":"Amino acid\u2013modified triterpenoids as potent antitumor agents: synthesis, characterization and biological evaluation","volume":"509","author":"Zhang","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118336_bib11","first-page":"3842","article-title":"Neuroprotective effects of boswellic acids via modulation of oxidative stress and inflammatory pathways","volume":"53","author":"Ghosh","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118336_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.copbio.2004.10.001","article-title":"Carbohydrate diversity: synthesis of glycoconjugates and complex carbohydrates","volume":"15","author":"H\u00f6lemann","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118336_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cbic.200800546","article-title":"The structural diversity of acidic lipopeptide antibiotics","volume":"10","author":"Strieker","year":"2009","journal-title":"Chembiochem: a European journal of chemical biology"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118336_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0958-1669(99)80013-5","article-title":"Applications of peptide nucleic acids","volume":"10","author":"Nielsen","year":"1999","journal-title":"Curr. Opin. Biotechnol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118336_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118336_bib16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0960-894X(99)00165-1","article-title":"Preparation of amino acid conjugates of betulinic acid with activity against human melanoma","volume":"9","author":"Jeong","year":"1999","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118336_bib17","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1021\/mp200447r","article-title":"Ethylene glycol-linked amino acid diesterprodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics","volume":"9","author":"Cao","year":"2012","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118336_bib18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/molecules17021278","article-title":"Synthesis, characterization and cytotoxicity of new rotundic acid derivatives","volume":"17","author":"He","year":"2012","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118336_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/jm3015684","article-title":"A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20' urea derivatives","volume":"56","author":"Leggans","year":"2013","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118336_bib20","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1021\/jm301201z","article-title":"Flavaglines as potent anti-cancer and cytoprotective agents","volume":"55","author":"Ribeiro","year":"2012","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118336_bib21","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1016\/j.bmcl.2014.08.007","article-title":"Design, synthesis and biological evaluation of \u03b2-boswellic acid based HDAC inhibitors as inducers of cancer cell death","volume":"24","author":"Sharma","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118336_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bmcl.2015.11.027","article-title":"Synthesis of \u03b2-boswellic acid derivatives as cytotoxic and apoptotic agents","volume":"26","author":"Kumar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"13","key":"10.1016\/j.ejmech.2025.118336_bib23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118336_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118336_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J. Chem. Theor. Comput."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118336_bib26","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118336_bib27","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/acsomega.0c05307","article-title":"Tandem MS-Based metabolite profiling of 19,20-Epoxycytochalasin C reveals the importance of a hydroxy group at the C7 position for biological activity","volume":"6","author":"Kushwaha","year":"2021","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118336_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/adt.2009.0222","article-title":"ADP-Glo: a bioluminescent and homogeneous ADP monitoring assay for kinases","volume":"7","author":"Zegzouti","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118336_bib29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mc.22828","article-title":"Dual role of Par-4 in abrogation of EMT and switching on mesenchymal to epithelial transition (MET) in metastatic pancreatic cancer cells","volume":"57","author":"Katoch","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118336_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1021\/acsptsci.1c00228","article-title":"2-Pyridin-4-yl-methylene-beta-boswellic Acid-A potential candidate for targeting O6-Methylguanine-DNA methyltransferase epi-transcriptional reprogramming in KRAS G13D-Microsatellite stable, G12V-Microsatellite instable mutant Colon cancer","volume":"5","author":"Qayum","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118336_bib31","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/mc.22457","article-title":"A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis","volume":"55","author":"Hussain","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118336_bib32","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio-protocol"},{"issue":"15","key":"10.1016\/j.ejmech.2025.118336_bib33","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.3748\/wjg.v22.i15.3952","article-title":"Gallic acid induced apoptotic events in HCT-15 colon cancer cells","volume":"22","author":"Subramanian","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118336_bib34","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118336_bib35","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/nprot.2009.191","article-title":"Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo","volume":"4","author":"Debacq-Chainiaux","year":"2009","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118336_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1474-9726.2006.00199.x","article-title":"Senescence-associated beta-galactosidase is lysosomal beta-galactosidase","volume":"5","author":"Lee","year":"2006","journal-title":"Aging Cell"},{"issue":"Pt 20","key":"10.1016\/j.ejmech.2025.118336_bib37","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1242\/jcs.113.20.3613","article-title":"Senescence-associated (Beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells","volume":"113","author":"Kurz","year":"2000","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118336_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2008.06.005","article-title":"Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence","volume":"14","author":"Ansieau","year":"2008","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118336_bib39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/MCB.16.3.859","article-title":"Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence","volume":"16","author":"Hara","year":"1996","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118336_bib40","first-page":"2485","article-title":"Electron microscopic analysis of different cell types in human pancreatic cancer spheres","volume":"15","author":"Ishiwata","year":"2018","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118336_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/biology10090929","article-title":"The ultrastructural analysis of human colorectal cancer stem cell-derived spheroids and their mouse xenograft shows that the same cells types have different ratios","volume":"10","author":"Relucenti","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.ejmech.2025.118336_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40005-017-0350-8","article-title":"In-vitro and in-vivo pharmacokinetics of IS01957, p-coumaric acid derivative using a validated LC\u2013ESI\u2013MS\/MS method in mice plasma","volume":"48","author":"Sharma","year":"2018","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118336_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/00498254.2021.1883769","article-title":"Amalgamation of in-silico, in-vitro and in-vivo approach to establish glabridin as a potential CYP2E1 inhibitor","volume":"51","author":"Bhatt","year":"2021","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"10.1016\/j.ejmech.2025.118336_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110109","article-title":"Rottlerin promotes anti-metastatic events by ameliorating pharmacological parameters of paclitaxel: an in-vivo investigation in the orthotopic mouse model of breast cancer","volume":"366","author":"Manhas","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118336_bib45","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/acs.jmedchem.7b01765","article-title":"Discovery and preclinical development of IIIM-290, an orally active potent cyclin-dependent kinase inhibitor","volume":"61","author":"Bharate","year":"2018","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118336_bib46","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/mc.22457","article-title":"A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis","volume":"55","author":"Hussain","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118336_bib47","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ejps.2012.08.013","article-title":"Anti-cancer activity, toxicity and pharmacokinetic profile of an indanone derivative","volume":"47","author":"Chanda","year":"2012","journal-title":"Eur. J. Pharmaceut. Sci. : official journal of the European Federation for Pharmaceutical Sciences"},{"key":"10.1016\/j.ejmech.2025.118336_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pupt.2017.11.006","article-title":"Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach","volume":"48","author":"Magotra","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118336_bib49","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1021\/acsabm.9b00423","article-title":"Hyaluronic acid-tacrolimus bioconjugate: synthesis, characterization, and pharmacokinetic investigation of an acid-responsive macromolecular prodrug","volume":"2","author":"Dheer","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"78","key":"10.1016\/j.ejmech.2025.118336_bib50","doi-asserted-by":"crossref","first-page":"74586","DOI":"10.1039\/C6RA14929D","article-title":"PLGA nanoparticles augmented the anti-cancer potential of pentacyclic triterpenediol in vivo in mice","volume":"6","author":"Dubey","year":"2016","journal-title":"RSC Adv."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:00:08Z","timestamp":1780909208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0223523425011018"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118336","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of \u03b2-boswellic acid-amino acid conjugates for targeting KRASG13D mutant colon cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118336"}}